Effectiveness of Enarodustat for renal anemia with chronic heart failure: A prospective observation study

Effectiveness of Enarodustat for renal anemia with chronic heart failure - Effectiveness of Enarodustat for renal anemia with chronic heart failure

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000050496

Enrollment

Registered

2023-03-06

Start date

2022-05-17

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Renal anemia with chronic heart failure using CERA

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Renal anemia with chronic heart failure

Exclusion criteria

Exclusion criteria: Patients who were deemed not appropriate to participate in this study by doctor

Design outcomes

Primary

Measure	Time frame
Hb	—

Secondary

Measure	Time frame
1) NTProBNP, BNP, ANP 2) NYHA class 3) cardiac function by UCG (EF, LVDd, LVMI, E/e') 4) serum Cr, eGFR 5) hs-CRP 6) cystatin C 7) ox-LDL 8)Urinary Albumin 9) renin, angiotensin-II, aldosterone 10) EPO 11) Fe, UIBC, Ferritin 12)T3,T4,TSH 13) side effect	—

Countries

Japan

Contacts

Public ContactMitsue Akiyama

Sekino Laboratory Department of Research

skn-np@sekino-hospital.com03-3986-5501

Outcome results